Quest Diagnostics (DGX) Non Operating Income (2016 - 2025)
Quest Diagnostics' Non Operating Income history spans 17 years, with the latest figure at -$56.0 million for Q4 2025.
- For Q4 2025, Non Operating Income rose 9.68% year-over-year to -$56.0 million; the TTM value through Dec 2025 reached -$238.0 million, down 39.18%, while the annual FY2025 figure was -$238.0 million, 39.18% down from the prior year.
- Non Operating Income for Q4 2025 was -$56.0 million at Quest Diagnostics, up from -$58.0 million in the prior quarter.
- Across five years, Non Operating Income topped out at $322.0 million in Q2 2021 and bottomed at -$132.0 million in Q4 2022.
- The 5-year median for Non Operating Income is -$31.5 million (2021), against an average of -$18.0 million.
- The largest annual shift saw Non Operating Income surged 1250.0% in 2021 before it crashed 1625.0% in 2022.
- A 5-year view of Non Operating Income shows it stood at -$34.0 million in 2021, then crashed by 288.24% to -$132.0 million in 2022, then skyrocketed by 107.58% to $10.0 million in 2023, then tumbled by 720.0% to -$62.0 million in 2024, then grew by 9.68% to -$56.0 million in 2025.
- Per Business Quant, the three most recent readings for DGX's Non Operating Income are -$56.0 million (Q4 2025), -$58.0 million (Q3 2025), and -$54.0 million (Q2 2025).